Patient Adherence to Venous Thromboembolism Prophylaxis in Orthopaedic Trauma Patients: A Randomized, Controlled Trial Comparing Subcutaneous Enoxaparin & Oral Rivaroxaban
Latest Information Update: 06 Jan 2022
At a glance
- Drugs Enoxaparin sodium (Primary) ; Rivaroxaban (Primary) ; Aspirin
- Indications Deep vein thrombosis; Venous thromboembolism
- Focus Therapeutic Use
Most Recent Events
- 06 Jan 2022 According to ClinicalTrials.gov, the recruitment status of this study is unknown because the information has not been verified recently (last verified Jan 2020).
- 15 Jan 2020 Status changed from not yet recruiting to recruiting.
- 21 Nov 2019 New trial record